Are There Any New Treatment Options for MPN Patients With Anemia?

Published on

Topics include: Treatment and Understanding

What’s available for myeloproliferative neoplasm (MPN) patients with a low hemoglobin? Dr. Naveen Pemmaraju, from The University of Texas MD Anderson Cancer Center, gives an update on anemia-targeted drugs in development for those living with myelofibrosis (MF) and myelodysplastic syndrome (MDS). How can patients get involved with this important clinical research? Dr. Pemmaraju also shares valuable resources to help MPN patients get connected to suitable clinical trials. Watch now to find out the latest treatment news for MPN-related anemia.

This is a Patient Empowerment Network program. We thank Incyte Corporation for their support.

View more programs featuring and

Produced in association with

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Andrew Schorr:

Roger says, “Are there any drugs being studied that improve anemia in patients with a low hemoglobin?” What’s the easiest way to find out about clinical trials if you live out of the state, or out of the country where this trial may be. 

Dr. Pemmaraju:           

Yes. Your best resource to look that up is run by the Federal Government, the NH, it’s called clinicaltrials.gov, that’s dot G-O-V. This is an outstanding website, well curated, updated as quickly as they can, and it has a nice search function. You can search by investigator, disease type, condition, and there’s even a box for “other” where you can type in something like “myelofibrosis”. 

There are several drugs in development. These drugs are known as luspatercept and sotatercept, for example. And they’re a class of drugs that are anemia targeting in myelofibrosis and myelodysplastic syndrome. So, the answer is, yes. And you can find out these types of clinical trials either online at this website, or at other websites. But this is an important, urgent, unmet medical need that we are working on, and there are active clinical trials for patients to enroll on. 

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

Are There Treatment Options for Transfusion-Dependent MPN Patients?

What therapies are available to patients with low hemoglobin levels? Can the need for transfusions be reduced? Watch now to hear a panel of experts discuss treatment options for MPN-related anemia.

Published:

How Do I Manage My Risk for Clotting As I Age With Essential Thrombocythemia (ET)?

During this Ask the Expert segment, a community member with essential thrombocythemia (ET) wants to know about increased risk for clotting as they age and how to prevent blood clots with their condition. Dr. Abdulraheem Yacoub responds.

Published:

Should Polycythemia Vera Patients Avoid Vitamin K?

Watch now to hear MPN expert Dr. Naveen Pemmaraju explain the effect vitamin K has on iron levels, how it may interact with treatment and what patients should consider when it comes to diet.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on December 11, 2018